Merck snags Elanco's coccidiosis treatment for $55 millionFebruary 20, 2020Elanco Animal Health has unloaded its proprietary oral drench treatment for coccidiosis in calves and lambs to Merck Animal Health in an all-cash deal totaling $55 million.
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
AAVMC, Merck division unite on AMR projectDecember 10, 2019The Association of American Veterinary Medical Colleges (AAVMC) has joined forces with MSD Animal Health, a division of Merck & Co., on an international grant program designed to mitigate global health concerns surrounding antimicrobial resistance (AMR).
